Muscarinic acetylcholine receptor M1 mutations causing neurodevelopmental disorder and epilepsy, 2021 (3.803Mb)
Muscarinic acetylcholine receptor M1 mutations causing neurodevelopmental disorder and epilepsy, 2021. Material suplementari 1 (199.3Kb)
De novo rare damaging variants in genes involved in critical developmental pathways, notably regulation of synaptic transmission, have emerged as a frequent cause of neurodevelopmental disorders (NDD). NDD show great locus heterogeneity and for many of the associated genes, there is substantial phenotypic diversity, including epilepsy, intellectual disability, autism spectrum disorder, movement disorders, and combinations thereof. We report two unrelated patients, a young girl with early-onset refractory epilepsy, severe disability, and progressive cerebral and cerebellar atrophy, and a second girl with mild dysmorphism, global developmental delay, and moderate intellectual disability in whom trio-based whole-exome sequencing analysis uncovered de novo missense variants in CHRM1. Biochemical analyses of one of the NDD-associated variants proved that it caused a reduction in protein levels and impaired cellular trafficking. In addition, the mutated receptor showed defective activation of intracellular signaling pathways. Our data strengthen the concept that brain-reduced muscarinic signaling lowers the seizure threshold and severely impairs neurodevelopment.
Epileptic encephalopathy; Muscarinic receptor; Whole-exome sequencing
Marcé-Grau A, Elorza-Vidal X, Pérez-Rius C, Ruiz-Nel·lo A, Sala-Coromina J, Gabau E, et al. Muscarinic acetylcholine receptor M1 mutations causing neurodevelopmental disorder and epilepsy. Hum Mutat. 2021 Oct;42(10):1215–20.
Use this identifier for quote and/or link this documenthttp://hdl.handle.net/11351/6925
This item appears in following collections
The following license files are associated with this item: